Globe Newswire News Releases

May 08, 2024 07:30 ET
Kura Oncology to Participate in Bank of America Securities Healthcare Conference
Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced its participation in Bank of America Securities 2024 Healthcare...
May 08, 2024 07:30 ET
Metasphere Labs Inc. Finalizes Strategic Partnership with Bot Ventures Inc. to Lead in Bitcoin-Based Decentralized Identity Solutions
Metasphere Labs Inc. ("Metasphere" or the "Company") (Cboe Canada: LABZ) (OTC: LABZF) (FRA: H1N) is excited to announce a definitive agreement with Bot Ventures Inc. (“Bot Ventures”), an innovator in the identity, naming, and verification space...
May 08, 2024 07:30 ET
Nexxen to Announce First Quarter 2024 Financial Results on May 20, 2024
Nexxen International Ltd. (AIM/NASDAQ: NEXN) (“Nexxen” or the “Company”), a global, unified advertising technology platform with deep expertise in video and Connected TV ("CTV"), will release its financial results for the first quarter ended March...
May 08, 2024 07:30 ET
Verrica Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results on May 13, 2024
Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that it will host a conference call and live...
May 08, 2024 07:28 ET
WEMADE and WEMIX Win “Best Web3 Gaming” at MENA Games Industry Awards 2024
WEMADE and WEMIX were honored with the prestigious "BEST WEB3 GAMING '' award at the MENA Games Industry Awards 2024. The awards celebrate the best of the region's thriving gaming sector, and as the sole web3-focused award, the "BEST WEB3...
May 08, 2024 07:25 ET
Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Third Review
Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that an independent Data Monitoring Committee...
May 08, 2024 07:25 ET
Ladybug Signs LOI to Purchase Ecommerce Site from Your Supplement Supply Store Ltd.
Ladybug Resource Group, Inc. (OTC PINK: LBRG), now operating under the brand name Ladybug NutraTech, is excited to announce the signing of a Letter of Intent for the acquisition of a leading e-commerce platform from Your Supplement Supply Store...
May 08, 2024 07:16 ET
WTW boosts global cyber facility with increased capacity and broader coverage options
WTW (NASDAQ: WTW), a leading global advisory, broking and solutions company, today announces strategic enhancements to its global cyber facility. Following a successful launch in January 2023, WTW’s CyXS facility, a global solution for excess cyber...
May 08, 2024 07:05 ET
Gilat Reports First Quarter 2024 Results
Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, today reported its results for the first quarter, ended March 31, 2024. First Quarter 2024 Financial...
May 08, 2024 07:00 ET
GDS to Report First Quarter 2024 Financial Results Before the Open of the U.S. Market on May 22, 2024
GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data centers in China and South East Asia, today announced that it will report its first quarter 2024...
May 08, 2024 07:00 ET
Amicus Therapeutics to Present at the Bank of America 2024 Health Care Conference
Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in a fireside chat at the Bank of America 2024 Health Care Conference in Las Vegas, NV on Wednesday, May 15, 2024, at 1:40 p.m. P.T. A live audio webcast of the...
May 08, 2024 07:00 ET
Axsome Therapeutics to Present at Upcoming Investor Conferences
Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced that Herriot Tabuteau, MD, Axsome’s Chief Executive...
May 08, 2024 07:00 ET
Chemomab Therapeutics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule
Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced that it received formal notification from...
May 08, 2024 07:00 ET
CRISPR Therapeutics Highlights ASGCT Oral Presentation and Announces New Programs Utilizing In Vivo Gene Editing Approach
CTX340™, targeting AGT in the liver, achieved durable editing of AGT and sustained ~30 mmHg blood pressure (BP) reduction out to 3 months in the spontaneously hypertensive rat (SHR) model, demonstrating its potential as a one-time therapeutic...
May 08, 2024 07:00 ET
EyePoint Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Corporate Developments
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, today announced financial results for the first quarter ended March...
May 08, 2024 07:00 ET
Inception Growth Acquisition Limited Announces Additional Contribution to Trust Account to Extend Business Combination Period
Inception Growth Acquisition Limited (NASDAQ: IGTA, the “Company”), a publicly traded special purpose acquisition company, announced today that on May 6, 2024, the Company deposited $100,000 into the Company’s trust account (the “Trust Account”)...
May 08, 2024 07:00 ET
MegaWatt Metals Provides Corporate Update, Including Advancing Clean-Energy Focus Through Agreement to Acquire Uranium Property
MegaWatt Lithium and Battery Metals Corp. (CSE:MEGA) (FSE: WR20) (OTCQB: WALRF) (the "Company", "MegaWatt Metals" or “MegaWatt”) is pleased to provide a corporate update regarding the Company’s recent developments and upcoming milestones....
May 08, 2024 07:00 ET
Multi Ways Holdings Expands Fleet with the Acquisition of 16 New Crawler Cranes
Multi Ways Holdings Limited (“Multi Ways” or the “Company”) (NYSE American: MWG), a leading supplier of a wide range of heavy construction equipment for sales and rental in Singapore and the surrounding region is pleased to announce its procurement...
May 08, 2024 07:00 ET
OKYO Pharma Announces Participation in May 2024 Investor Conferences
OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of inflammatory dry eye disease (DED), a multi-billion-dollar market, and anterior ocular segment diseases...